Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of 1% Clascoterone Cream in the Treatment of Acne Vulgaris
NCT07457294 is registered in ClinicalTrials.gov with Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of 1% Clascoterone Cream in the Treatment of Acne Vulgaris
- Lead sponsor
- Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- May 4, 2026
- Completion date
- February 7, 2029
- Enrollment
- 692 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.